Nukleus Office (544370)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Sales grew 18% and profit grew faster at 26.09%, showing improving profitability.
• Piotroski F-Score of 7/9 indicates generally sound financial health.
• ROCE of 11.87% shows the company is generating a positive return on capital employed.
• Latest quarter is profitable with ₹1 crore net profit on ₹17 crore sales.

Concerns

• P/E of 35.41 and PEG of 1.61 suggest the growth is largely priced in, leaving little margin of safety.
• Latest quarter net margin is only about 5.9%, reflecting a low-margin services business.
• No dividend yield of 0.00% means investors depend entirely on capital appreciation.
• Critical data like book value, debt/equity, and promoter holding are missing, raising governance and transparency concerns.

AI Analysis

Let's look at Nukleus Office the way I look at any business: what will it earn, how sure am I, and what price am I paying. This is an ₹81 crore company selling at ₹202 a share. At 35.41 times earnings, the market expects meaningful growth. To my liking, revenue grew 18% and profit grew faster at 26.09%, so the business is moving in the right direction. The latest quarter had ₹17 crore in sales and only ₹1 crore in net profit — a thin 5.9% margin. That tells me this is not a franchise with pricing power; it is a services business that must work hard for every rupee. The Piotroski score of 7/9 is a positive sign. It tells me the company is not financially deteriorating. ROCE of 11.87% is decent, but not the kind of extraordinary return on capital that creates a wide moat. And I cannot fully assess financial health because book value, debt-to-equity, and promoter holding are not disclosed. As Graham said, the investor's worst enemy is not the stock market but himself; here, the lack of information is a serious risk. The PEG ratio at 1.61 suggests the growth is mostly priced in. At 35.41 times earnings, I am paying a full price for a small, low-margin company with no dividend. If profit growth continues at 26%, the valuation can work; if not, the downside may be sharp. A bargain hunter would prefer a stronger margin of safety. I would keep this on a watch list, not buy it blindly.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer